| Fcγ receptors as regulators of immune responses F Nimmerjahn, JV Ravetch Nature Reviews Immunology 8 (1), 34, 2008 | 2151 | 2008 |
| Anti-inflammatory activity of immunoglobulin G resulting from Fc sialylation Y Kaneko, F Nimmerjahn, JV Ravetch science 313 (5787), 670-673, 2006 | 1499 | 2006 |
| Fcγ receptors: old friends and new family members F Nimmerjahn, JV Ravetch Immunity 24 (1), 19-28, 2006 | 1101 | 2006 |
| Divergent immunoglobulin g subclass activity through selective Fc receptor binding F Nimmerjahn, JV Ravetch Science 310 (5753), 1510-1512, 2005 | 932 | 2005 |
| Recapitulation of IVIG anti-inflammatory activity with a recombinant IgG Fc RM Anthony, F Nimmerjahn, DJ Ashline, VN Reinhold, JC Paulson, ... Science 320 (5874), 373-376, 2008 | 695 | 2008 |
| FcγRIV: a novel FcR with distinct IgG subclass specificity F Nimmerjahn, P Bruhns, K Horiuchi, JV Ravetch Immunity 23 (1), 41-51, 2005 | 669 | 2005 |
| Intravenous immunoglobulin therapy: how does IgG modulate the immune system? I Schwab, F Nimmerjahn Nature Reviews Immunology 13 (3), 176, 2013 | 503 | 2013 |
| Induction of osteoclastogenesis and bone loss by human autoantibodies against citrullinated vimentin U Harre, D Georgess, H Bang, A Bozec, R Axmann, E Ossipova, ... The Journal of clinical investigation 122 (5), 1791-1802, 2012 | 501 | 2012 |
| Anti-inflammatory actions of intravenous immunoglobulin F Nimmerjahn, JV Ravetch Annu. Rev. Immunol. 26, 513-533, 2008 | 491 | 2008 |
| Cutting edge: Mincle is essential for recognition and adjuvanticity of the mycobacterial cord factor and its synthetic analog trehalose-dibehenate H Schoenen, B Bodendorfer, K Hitchens, S Manzanero, K Werninghaus, ... The Journal of Immunology 184 (6), 2756-2760, 2010 | 375 | 2010 |
| Fc‐receptors as regulators of immunity F Nimmerjahn, JV Ravetch Advances in immunology 96, 179-204, 2007 | 373 | 2007 |
| Major histocompatibility complex class II‐restricted presentation of a cytosolic antigen by autophagy F Nimmerjahn, S Milosevic, U Behrends, EM Jaffee, DM Pardoll, ... European journal of immunology 33 (5), 1250-1259, 2003 | 319 | 2003 |
| Anti-inflammatory activity of IgG1 mediated by Fc galactosylation and association of FcγRIIB and dectin-1 CM Karsten, MK Pandey, J Figge, R Kilchenstein, PR Taylor, M Rosas, ... Nature medicine 18 (9), 1401, 2012 | 288 | 2012 |
| The antiinflammatory activity of IgG: the intravenous IgG paradox F Nimmerjahn, JV Ravetch Journal of Experimental Medicine 204 (1), 11-15, 2007 | 278 | 2007 |
| Antibodies, Fc receptors and cancer F Nimmerjahn, JV Ravetch Current opinion in immunology 19 (2), 239-245, 2007 | 254 | 2007 |
| The inhibitory Fcγ receptor modulates autoimmunity by limiting the accumulation of immunoglobulin G+ anti-DNA plasma cells H Fukuyama, F Nimmerjahn, JV Ravetch Nature immunology 6 (1), 99, 2005 | 253 | 2005 |
| Adjuvanticity of a synthetic cord factor analogue for subunit Mycobacterium tuberculosis vaccination requires FcRγ–Syk–Card9–dependent innate immune activation K Werninghaus, A Babiak, O Groß, C Hölscher, H Dietrich, EM Agger, ... Journal of Experimental Medicine 206 (1), 89-97, 2009 | 252 | 2009 |
| Antibody‐mediated modulation of immune responses F Nimmerjahn, JV Ravetch Immunological reviews 236 (1), 265-275, 2010 | 248 | 2010 |
| Antibody isotype-specific engagement of Fcγ receptors regulates B lymphocyte depletion during CD20 immunotherapy Y Hamaguchi, Y Xiu, K Komura, F Nimmerjahn, TF Tedder Journal of experimental medicine 203 (3), 743-753, 2006 | 245 | 2006 |
| Pathology and protection in nephrotoxic nephritis is determined by selective engagement of specific Fc receptors Y Kaneko, F Nimmerjahn, MP Madaio, JV Ravetch Journal of Experimental Medicine 203 (3), 789-797, 2006 | 232 | 2006 |
Jeffrey RavetchRockefeller UniversityBestätigte E-Mail-Adresse bei rockefeller.edu
